BLSH(BLSH)
BLSH
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $367M | $425M | $449M | $674M |
| Low | $359M | $409M | $426M | $640M |
| High | $384M | $441M | $471M | $706M |
| EBITDA Avg | $-74M | $-86M | $-91M | $-136M |
| Low | $-78M | $-89M | $-95M | $-143M |
| High | $-73M | $-83M | $-86M | $-129M |
| EBIT Avg | $-74M | $-86M | $-91M | $-136M |
| Low | $-78M | $-89M | $-95M | $-143M |
| High | $-73M | $-83M | $-86M | $-129M |
| Net Income Avg | $71M | $115M | $147M | $285M |
| Low | $61M | $97M | $137M | $266M |
| High | $90M | $132M | $156M | $303M |
| EPS Avg | $0.56 | $0.90 | $1.15 | $2.23 |
| Low | $0.48 | $0.76 | $1.07 | $2.09 |
| High | $0.70 | $1.04 | $1.22 | $2.37 |
| Analysts (Rev / EPS) | 5 / 5 | 5 / 2 | 1 / 1 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $90M | $97M | $102M | $107M | $107M | $111M |
| Low | $84M | $90M | $94M | $99M | $99M | $102M |
| High | $98M | $106M | $112M | $117M | $117M | $121M |
| EBITDA Avg | $-18M | $-20M | $-21M | $-22M | $-22M | $-22M |
| Low | $-20M | $-21M | $-23M | $-24M | $-24M | $-25M |
| High | $-17M | $-18M | $-19M | $-20M | $-20M | $-21M |
| EBIT Avg | $-18M | $-20M | $-21M | $-22M | $-22M | $-22M |
| Low | $-20M | $-21M | $-23M | $-24M | $-24M | $-25M |
| High | $-17M | $-18M | $-19M | $-20M | $-20M | $-21M |
| Net Income Avg | $21M | $27M | $32M | $35M | $38M | $42M |
| Low | $14M | $25M | $29M | $32M | $34M | $38M |
| High | $30M | $31M | $36M | $40M | $43M | $47M |
| EPS Avg | $0.14 | $0.18 | $0.21 | $0.23 | $0.25 | $0.28 |
| Low | $0.09 | $0.16 | $0.19 | $0.21 | $0.23 | $0.25 |
| High | $0.20 | $0.20 | $0.24 | $0.26 | $0.28 | $0.31 |
| Analysts (Rev / EPS) | 5 / 2 | 2 / 1 | 2 / 1 | 4 / 1 | 4 / 1 | 2 / 1 |